ENZYMATIC DETERMINANTS OF RESPONSE TO CYTOSINE-ARABINOSIDE (ARA-C) IN PATIENTS (PTS) WITH ACUTE MYELOID-LEUKEMIA (AML)

被引：0
作者：
RIVA, CM [1 ]
DESOUZA, G [1 ]
FERRIER, F [1 ]
MERLIN, M [1 ]
TUBIANA, N [1 ]
LEJEUNE, C [1 ]
GASTAUT, JA [1 ]
BARRA, Y [1 ]
CANO, JP [1 ]
CARCASSONNE, Y [1 ]
机构：
[1] INST J PAOLI I CALMETTES,INSERM,U278,F-13009 MARSEILLE,FRANCE
来源：
PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH | 1988年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：502 / 502
页数：1
相关论文
共 50 条
  • [31] The proliferative activity of acute myeloid leukemia (AML) blasts is a major determinand for cytosine arabinoside (Ara-C) mediated pharmacodynamics.
    Braess, J
    Jahns-Streubel, G
    Voss, S
    Schoch, C
    Kem, W
    Hiddemann, W
    BLOOD, 1999, 94 (10) : 508A - 508A
  • [32] TREATMENT OF ADULT ACUTE MYELOID-LEUKEMIA (AML) WITH MITOXANTRONE AND CYTOSINE-ARABINOSIDE - EXPERIENCE AFTER ONE YEAR
    DHARMASENA, F
    CATOVSKY, D
    GALTON, DAG
    GOLDMAN, JM
    MARCUS, RE
    SLOCOMBE, G
    NEWLAND, AC
    BRITISH JOURNAL OF HAEMATOLOGY, 1986, 64 (04) : 813 - 814
  • [33] LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE-LEUKEMIA
    WINTER, JN
    VARIAKOJIS, D
    GAYNOR, ER
    LARSON, RA
    MILLER, KB
    CANCER, 1985, 56 (03) : 443 - 449
  • [34] LOW-DOSE CYTOSINE-ARABINOSIDE (ARA-C) THERAPY IN THE MYELODYSPLASTIC SYNDROMES AND ACUTE MYELOGENOUS LEUKEMIA
    MAIOLO, AT
    FOA, P
    CORTELLARO, M
    LAMBERTENGHIDELILIERS, G
    COLANTONI, A
    CESANA, B
    CASTOLDI, GL
    CAZZOLA, M
    GIORDANO, M
    RICCARDI, A
    POLLI, EE
    HAEMATOLOGICA, 1987, 72 (01) : 61 - 65
  • [35] THE COST-EFFECTIVENESS OF IDARUBICIN CYTOSINE-ARABINOSIDE VERSUS DAUNORUBICIN CYTOSINE-ARABINOSIDE IN THE TREATMENT OF ADULTS WITH ACUTE MYELOID-LEUKEMIA
    PASHKO, S
    JACOBS, J
    SANTORSA, J
    CLINICAL THERAPEUTICS, 1991, 13 (03) : 353 - 360
  • [36] IDARUBICIN AND HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C) IN REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) PATIENTS
    SPIRITI, MAA
    TESTI, AM
    AMADORI, S
    DEFABRITIIS, P
    GIONA, F
    SANDRELLI, A
    MELONI, G
    ACTA HAEMATOLOGICA, 1987, 78 : 213 - 213
  • [37] INHIBITION OF CYTOSINE-ARABINOSIDE (ARA-C) DEAMINATION BY URIDINE ANALOGS
    HANDE, K
    LEWIS, B
    CHABNER, B
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1978, 19 (MAR): : 149 - 149
  • [38] CYTOSINE-ARABINOSIDE (ARA-C) DEAMINATION IN HUMAN-LEUKEMIC MARROW AND RESISTANCE TO ARA-C
    HARRIS, AL
    GRAHAMESMITH, DG
    BRITISH JOURNAL OF CANCER, 1980, 42 (01) : 172 - 172
  • [39] PHARMACOKINETICS OF HIGH-DOSE CYTOSINE-ARABINOSIDE (ARA-C)
    HANDE, KR
    STEIN, RS
    MCDONOUGH, DA
    WOLFF, SN
    CLINICAL RESEARCH, 1981, 29 (02): : A436 - A436
  • [40] POTENTIATION OF ARA-C (CYTOSINE-ARABINOSIDE) THERAPEUTIC EFFECTS BY NITROBENZYLTHIOINOSINE
    CASS, CE
    PATERSON, AR
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1974, 15 (MAR): : 18 - 18
12345